Single-cell genomic variation induced by mutational processes in cancer.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
12 2022
Historique:
received: 03 06 2021
accepted: 17 08 2022
pubmed: 27 10 2022
medline: 3 12 2022
entrez: 26 10 2022
Statut: ppublish

Résumé

How cell-to-cell copy number alterations that underpin genomic instability

Identifiants

pubmed: 36289342
doi: 10.1038/s41586-022-05249-0
pii: 10.1038/s41586-022-05249-0
pmc: PMC9712114
doi:

Substances chimiques

TP53 protein, human 0
BRCA1 protein, human 0
BRCA2 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-115

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NHGRI NIH HHS
ID : RM1 HG011014
Pays : United States
Organisme : Cancer Research UK
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : K99 CA256508
Pays : United States

Investigateurs

Gregory J Hannon (GJ)
Georgia Battistoni (G)
Dario Bressan (D)
Ian G Cannell (IG)
Hannah Casbolt (H)
Cristina Jauset (C)
Tatjana Kovačević (T)
Claire M Mulvey (CM)
Fiona Nugent (F)
Marta Paez Ribes (MP)
Isabella Pearson (I)
Fatime Qosaj (F)
Kirsty Sawicka (K)
Sophia A Wild (SA)
Elena Williams (E)
Emma Laks (E)
Austin Smith (A)
Daniel Lai (D)
Andrew Roth (A)
Shankar Balasubramanian (S)
Maximilian Lee (M)
Bernd Bodenmiller (B)
Marcel Burger (M)
Laura Kuett (L)
Sandra Tietscher (S)
Jonas Windhager (J)
Edward S Boyden (ES)
Shahar Alon (S)
Yi Cui (Y)
Amauche Emenari (A)
Daniel R Goodwin (DR)
Emmanouil D Karagiannis (ED)
Anubhav Sinha (A)
Asmamaw T Wassie (AT)
Carlos Caldas (C)
Alejandra Bruna (A)
Maurizio Callari (M)
Wendy Greenwood (W)
Giulia Lerda (G)
Yaniv Eyal-Lubling (Y)
Oscar M Rueda (OM)
Abigail Shea (A)
Owen Harris (O)
Robby Becker (R)
Flaminia Grimaldo (F)
Suvi Harris (S)
Sara Lisa Vogl (SL)
Johanna A Joyce (JA)
Spencer S Watson (SS)
Simon Tavare (S)
Khanh N Dinh (KN)
Eyal Fisher (E)
Russell Kunes (R)
Nicholas A Walton (NA)
Mohammed Al Sa'd (M)
Nick Chornay (N)
Ali Dariush (A)
Eduardo A González-Solares (EA)
Carlos González-Fernández (C)
Aybüke Küpcü Yoldaş (AK)
Neil Miller (N)
Xiaowei Zhuang (X)
Jean Fan (J)
Hsuan Lee (H)
Leonardo A Sepúlveda (LA)
Chenglong Xia (C)
Pu Zheng (P)

Informations de copyright

© 2022. The Author(s).

Références

Umbreit, N. T. et al. Mechanisms generating cancer genome complexity from a single cell division error. Science 368, eaba0712 (2020).
pubmed: 32299917 pmcid: 7347108 doi: 10.1126/science.aba0712
Minussi, D. C. et al. Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature 592, 302–308 (2021).
pubmed: 33762732 pmcid: 8049101 doi: 10.1038/s41586-021-03357-x
Laks, E. et al. Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing. Cell 179, 1207–1221 (2019).
pubmed: 31730858 pmcid: 6912164 doi: 10.1016/j.cell.2019.10.026
Hakem, R. DNA-damage repair; the good, the bad, and the ugly. EMBO J. 27, 589–605 (2008).
pubmed: 18285820 pmcid: 2262034 doi: 10.1038/emboj.2008.15
Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112–121 (2020).
pubmed: 32025012 pmcid: 7025897 doi: 10.1038/s41586-019-1913-9
Macintyre, G. et al. Copy number signatures and mutational processes in ovarian carcinoma. Nat. Genet. 50, 1262–1270 (2018).
pubmed: 30104763 pmcid: 6130818 doi: 10.1038/s41588-018-0179-8
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
pubmed: 23945592 pmcid: 3776390 doi: 10.1038/nature12477
Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47–54 (2016).
pubmed: 27135926 pmcid: 4910866 doi: 10.1038/nature17676
Shiraishi, Y., Tremmel, G., Miyano, S. & Stephens, M. A simple model-based approach to inferring and visualizing cancer mutation signatures. PLoS Genet. 11, e1005657 (2015).
pubmed: 26630308 pmcid: 4667891 doi: 10.1371/journal.pgen.1005657
Funnell, T. et al. Integrated structural variation and point mutation signatures in cancer genomes using correlated topic models. PLoS Comput. Biol. 15, e1006799 (2019).
pubmed: 30794536 pmcid: 6402697 doi: 10.1371/journal.pcbi.1006799
Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346–352 (2012).
doi: 10.1038/nature10983 pubmed: 22522925 pmcid: 3440846
Wang, Y. et al. Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes. Nat. Genet. 49, 856–865 (2017).
pubmed: 28436987 doi: 10.1038/ng.3849
Davies, H. et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat. Med. 23, 517–525 (2017).
pubmed: 28288110 pmcid: 5833945 doi: 10.1038/nm.4292
Staaf, J. et al. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. Nat. Med. 25, 1526–1533 (2019).
pubmed: 31570822 pmcid: 6859071 doi: 10.1038/s41591-019-0582-4
Zahn, H. et al. Scalable whole-genome single-cell library preparation without preamplification. Nat. Methods 14, 167–173 (2017).
pubmed: 28068316 doi: 10.1038/nmeth.4140
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94–101 (2020).
pubmed: 32025018 pmcid: 7054213 doi: 10.1038/s41586-020-1943-3
Nguyen, L., W M Martens, J., Van Hoeck, A. & Cuppen, E. Pan-cancer landscape of homologous recombination deficiency. Nat. Commun. 11, 5584 (2020).
pubmed: 33149131 pmcid: 7643118 doi: 10.1038/s41467-020-19406-4
Salehi, S. et al. Clonal fitness inferred from time-series modelling of single-cell cancer genomes. Nature 595, 585–590 (2021).
pubmed: 34163070 pmcid: 8396073 doi: 10.1038/s41586-021-03648-3
Burleigh, A. et al. A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation. Breast Cancer Res. 17, 4 (2015).
pubmed: 25572802 pmcid: 4322558 doi: 10.1186/s13058-014-0510-y
Schwarz, R. F. et al. Phylogenetic quantification of intra-tumour heterogeneity. PLoS Comput. Biol. 10, e1003535 (2014).
pubmed: 24743184 pmcid: 3990475 doi: 10.1371/journal.pcbi.1003535
Wu, C.-Y. et al. Integrative single-cell analysis of allele-specific copy number alterations and chromatin accessibility in cancer. Nat. Biotechnol. 39, 1259–1269 (2021).
pubmed: 34017141 pmcid: 9127226 doi: 10.1038/s41587-021-00911-w
Zaccaria, S. & Raphael, B. J. Characterizing allele- and haplotype-specific copy numbers in single cells with CHISEL. Nat. Biotechnol. 39, 207–214 (2021).
pubmed: 32879467 doi: 10.1038/s41587-020-0661-6
Wang, Y. et al. The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy. Mol. Cancer 13, 94 (2014).
pubmed: 24775809 pmcid: 4028103 doi: 10.1186/1476-4598-13-94
Lee, H. et al. Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2. Mol. Cell 4, 1–10 (1999).
pubmed: 10445022 doi: 10.1016/S1097-2765(00)80182-3
Zeira, R. & Raphael, B. J. Copy number evolution with weighted aberrations in cancer. Bioinformatics 36, i344–i352 (2020).
pubmed: 32657354 pmcid: 7355291 doi: 10.1093/bioinformatics/btaa470
Sanders, A. D. et al. Single-cell analysis of structural variations and complex rearrangements with tri-channel processing. Nat. Biotechnol. 38, 343–354 (2020).
Zakov, S., Kinsella, M. & Bafna, V. An algorithmic approach for breakage-fusion-bridge detection in tumor genomes. Proc. Natl Acad. Sci. USA 110, 5546–5551 (2013).
pubmed: 23503850 pmcid: 3619374 doi: 10.1073/pnas.1220977110
Gisselsson, D. et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc. Natl Acad. Sci. USA 97, 5357–5362 (2000).
pubmed: 10805796 pmcid: 25833 doi: 10.1073/pnas.090013497
Watkins, T. B. K. et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587, 126–132 (2020).
pubmed: 32879494 pmcid: 7611706 doi: 10.1038/s41586-020-2698-6
Zhang, A. W. et al. Interfaces of malignant and immunologic clonal dynamics in ovarian cancer. Cell 173, 1755–1769 (2018).
pubmed: 29754820 doi: 10.1016/j.cell.2018.03.073
McPherson, A. et al. Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer. Nat. Genet. 48, 758–767 (2016).
pubmed: 27182968 doi: 10.1038/ng.3573
Patch, A.-M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489–494 (2015).
pubmed: 26017449 doi: 10.1038/nature14410
Eirew, P. et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature 518, 422–426 (2015).
pubmed: 25470049 doi: 10.1038/nature13952
Shah, S. P. et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486, 395–399 (2012).
pubmed: 22495314 doi: 10.1038/nature10933
Savage, P. et al. Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors. Commun. Biol. 3, 310 (2020).
pubmed: 32546838 pmcid: 7298048 doi: 10.1038/s42003-020-1042-x
Branton, D. et al. The potential and challenges of nanopore sequencing. Nat. Biotechnol. 26, 1146–1153 (2008).
pubmed: 18846088 pmcid: 2683588 doi: 10.1038/nbt.1495
Salehi, S. et al. Cancer phylogenetic tree inference at scale from 1000s of single cell genomes. Preprint at bioRxiv https://doi.org/10.1101/2020.05.06.058180 (2021).
Verhaak, R. G. W., Bafna, V. & Mischel, P. S. Extrachromosomal oncogene amplification in tumour pathogenesis and evolution. Nat. Rev. Cancer 19, 283–288 (2019).
pubmed: 30872802 pmcid: 7168519 doi: 10.1038/s41568-019-0128-6
Hadi, K. et al. Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs. Cell 183, 197–210 (2020).
pubmed: 33007263 pmcid: 7912537 doi: 10.1016/j.cell.2020.08.006
Annab, L. A. et al. Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation. Gynecol. Oncol. 77, 121–128 (2000).
pubmed: 10739701 doi: 10.1006/gyno.2000.5734
Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 47, D766–D773 (2019).
pubmed: 30357393 doi: 10.1093/nar/gky955
Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062–D1067 (2018).
pubmed: 29165669 doi: 10.1093/nar/gkx1153
Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941–D947 (2019).
pubmed: 30371878 doi: 10.1093/nar/gky1015
Létourneau, I. J. et al. Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer. BMC Cancer 12, 379 (2012).
pubmed: 22931248 pmcid: 3532154 doi: 10.1186/1471-2407-12-379
O’Flanagan, C. H. et al. Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responses. Genome Biol. 20, 210 (2019).
pubmed: 31623682 pmcid: 6796327 doi: 10.1186/s13059-019-1830-0
Ding, J. et al. Feature-based classifiers for somatic mutation detection in tumour–normal paired sequencing data. Bioinformatics 28, 167–175 (2012).
pubmed: 22084253 doi: 10.1093/bioinformatics/btr629
Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs. Bioinformatics 28, 1811–1817 (2012).
pubmed: 22581179 doi: 10.1093/bioinformatics/bts271
Chakravarty, D. et al. OncoKB: annotation of the oncogenic effect and treatment implications of somatic mutations in cancer. J. Clin. Oncol. 34, 11583–11583 (2016).
doi: 10.1200/JCO.2016.34.15_suppl.11583
McPherson, A., Shah, S. & Cenk Sahinalp, S. deStruct: accurate rearrangement detection using breakpoint specific realignment. Preprint at bioRxiv https://doi.org/10.1101/117523 (2017).
Layer, R. M., Chiang, C., Quinlan, A. R. & Hall, I. M. LUMPY: a probabilistic framework for structural variant discovery. Genome Biol. 15, R84 (2014).
pubmed: 24970577 pmcid: 4197822 doi: 10.1186/gb-2014-15-6-r84
Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094–3100 (2018).
pubmed: 29750242 pmcid: 6137996 doi: 10.1093/bioinformatics/bty191
Wick, R. R., Judd, L. M. & Holt, K. E. Performance of neural network basecalling tools for Oxford Nanopore sequencing. Genome Biol. 20, 129 (2019).
pubmed: 31234903 pmcid: 6591954 doi: 10.1186/s13059-019-1727-y
Shafin, K. et al. Haplotype-aware variant calling with PEPPER-Margin-DeepVariant enables high accuracy in nanopore long-reads. Nat. Methods 18, 1322–1332 (2021).
pubmed: 34725481 pmcid: 8571015 doi: 10.1038/s41592-021-01299-w
Martin, M. et al. WhatsHap: fast and accurate read-based phasing. Preprint at bioRxiv https://doi.org/10.1101/085050 (2016).
Sedlazeck, F. J. et al. Tools for annotation and comparison of structural variation. F1000Res. 6, 1795 (2017).
pubmed: 29123647 pmcid: 5668921 doi: 10.12688/f1000research.12516.1
Jiang, T. et al. Long-read-based human genomic structural variation detection with cuteSV. Genome Biol. 21, 189 (2020).
pubmed: 32746918 pmcid: 7477834 doi: 10.1186/s13059-020-02107-y
Nattestad, M., Aboukhalil, R., Chin, C.-S. & Schatz, M. C. Ribbon: intuitive visualization for complex genomic variation. Bioinformatics 37, 413–415 (2021).
pubmed: 32766814 doi: 10.1093/bioinformatics/btaa680
Gel, B. & Serra, E. karyoploteR: an R/Bioconductor package to plot customizable genomes displaying arbitrary data. Bioinformatics 33, 3088–3090 (2017).
pubmed: 28575171 pmcid: 5870550 doi: 10.1093/bioinformatics/btx346
Robinson, P. & Jtel, T. Z. in Computational Exome and Genome Analysis (eds Robinson, P. N., Piro, R. M. & Jäger, M.) 233–245 (2017).
Hornik, K. A CLUE for CLUster Ensembles. J. Stat. Softw. 14, 1–25 (2005).
McInnes, L., Healy, J. & Melville, J. UMAP: Uniform Manifold Approximation and Projection for dimension reduction. Preprint at arXiv https://doi.org/10.48550/arXiv.1802.03426 (2020).
McInnes, L. & Healy, J. Accelerated hierarchical density based clustering. In IEEE International Conference on Data Mining Workshops (ICDMW) 33–42 (IEEE, 2017).
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at arXiv https://doi.org/10.48550/arXiv.1303.3997 (2013).
Shah, S. P. et al. Integrating copy number polymorphisms into array CGH analysis using a robust HMM. Bioinformatics 22, e431–e439 (2006).
pubmed: 16873504 doi: 10.1093/bioinformatics/btl238
Wingett, S. W. & Andrews, S. FastQ Screen: a tool for multi-genome mapping and quality control. F1000Res. 7, 1338 (2018).
pubmed: 30254741 pmcid: 6124377 doi: 10.12688/f1000research.15931.1
Amemiya, H. M., Kundaje, A. & Boyle, A. P. The ENCODE blacklist: identification of problematic regions of the genome. Sci. Rep. 9, 9354 (2019).
Lee, S., Cook, D. & Lawrence, M. plyranges: a grammar of genomic data transformation. Genome Biol. 20, 4 (2019).
pubmed: 30609939 pmcid: 6320618 doi: 10.1186/s13059-018-1597-8
Yu, G. Using ggtree to visualize data on tree-like structures. Curr. Protoc. Bioinformatics 69, e96 (2020).
pubmed: 32162851 doi: 10.1002/cpbi.96
Paradis, E., Claude, J. & Strimmer, K. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20, 289–290 (2004).
pubmed: 14734327 doi: 10.1093/bioinformatics/btg412
Louca, S. & Doebeli, M. Efficient comparative phylogenetics on large trees. Bioinformatics 34, 1053–1055 (2018).
pubmed: 29091997 doi: 10.1093/bioinformatics/btx701
Werner, B. et al. Measuring single cell divisions in human tissues from multi-region sequencing data. Nat. Commun. 11, 1035 (2020).
pubmed: 32098957 pmcid: 7042311 doi: 10.1038/s41467-020-14844-6
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
pubmed: 29608179 pmcid: 6700744 doi: 10.1038/nbt.4096
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031
Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: Computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281–291 (2019).
pubmed: 30954476 pmcid: 6625319 doi: 10.1016/j.cels.2018.11.005
Huang, X. & Huang, Y. Cellsnp-lite: an efficient tool for genotyping single cells. Bioinformatics 37, 4569–4571 (2021).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289–300 (1995).

Auteurs

Tyler Funnell (T)

Tri-Institutional PhD Program in Computational Biology and Medicine, Weill Cornell Medicine, New York, NY, USA.
Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ciara H O'Flanagan (CH)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Marc J Williams (MJ)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. william1@mskcc.org.

Andrew McPherson (A)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Steven McKinney (S)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Farhia Kabeer (F)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Hakwoo Lee (H)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Sohrab Salehi (S)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ignacio Vázquez-García (I)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Hongyu Shi (H)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Emily Leventhal (E)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Tehmina Masud (T)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Peter Eirew (P)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Damian Yap (D)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Allen W Zhang (AW)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Jamie L P Lim (JLP)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Beixi Wang (B)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Jazmine Brimhall (J)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Justina Biele (J)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Jerome Ting (J)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Vinci Au (V)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Michael Van Vliet (M)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Yi Fei Liu (YF)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Sean Beatty (S)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Daniel Lai (D)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Jenifer Pham (J)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Diljot Grewal (D)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Douglas Abrams (D)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Eliyahu Havasov (E)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Samantha Leung (S)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Viktoria Bojilova (V)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Richard A Moore (RA)

Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Nicole Rusk (N)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Florian Uhlitz (F)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Nicholas Ceglia (N)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Adam C Weiner (AC)

Tri-Institutional PhD Program in Computational Biology and Medicine, Weill Cornell Medicine, New York, NY, USA.
Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Elena Zaikova (E)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

J Maxwell Douglas (JM)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Dmitriy Zamarin (D)

GYN Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Britta Weigelt (B)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Sarah H Kim (SH)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Arnaud Da Cruz Paula (A)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Jorge S Reis-Filho (JS)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Spencer D Martin (SD)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Yangguang Li (Y)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Hong Xu (H)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Teresa Ruiz de Algara (TR)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

So Ra Lee (SR)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Viviana Cerda Llanos (VC)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

David G Huntsman (DG)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Jessica N McAlpine (JN)

Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, British Columbia, Canada.

Sohrab P Shah (SP)

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. shahs3@mskcc.org.

Samuel Aparicio (S)

Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada. saparicio@bccrc.ca.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. saparicio@bccrc.ca.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH